NYSE:CIS (CIS) (CIS) Stock Price, News & Analysis → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free CIS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume67,812 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (CIS) alerts: Email Address Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read About (CIS) Stock (NYSE:CIS)Camelot Information Systems Inc. (Camelot) is a China-based company. The Company is a provider of business solutions and information technology services to the top 500 business corporations and financial institutions in mainland China, Taiwan, Hong Kong, and Japan through a network of 27 regional or local subsidiaries. The Company’s Enterprise Application Services (EAS) business provides Enterprise Resource Management (ERP), Customer Relationship Management (CRM), Manufacturing Execution System (MES), Supply-chain Management (SCM), and Application Development and Maintenance (ADM) services to its business corporation clients. The Company’s Financial Industry Services (FIS) business consists of a wide-range of solutions including Branch Front-end and Teller solutions, Financial Supply-Chain Management solutions, Operation Risk Management solutions, Regulatory Compliance solutions, and Life Insurance Core Application solutions.Read More Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read CIS Stock News HeadlinesMay 7, 2024 | msn.comSaengong signs supply deal with Shin Line Group in KazakhstanMay 7, 2024 | msn.comMississippi GOP passes bill to let cis people sue trans folks for using the bathroomMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.May 2, 2024 | msn.com14 states sue the Biden administration for the right to discriminate against trans kidsMay 2, 2024 | markets.businessinsider.comCognitus Launches Industry Solution to Revolutionize Aftermarket and MRO ServicesMay 1, 2024 | msn.comAbilene Gives: Communities in Schools of The Big CountryMay 1, 2024 | finance.yahoo.comSteelCloud Announces Partnership with CIS CyberMarketApril 28, 2024 | msn.comUnfavorably Attired Celebrities at the White House Correspondents’ Association DinnerMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.April 24, 2024 | msn.comTrans Women May Actually Face Several Disadvantages in Athletic Competition, Study FindsApril 23, 2024 | msn.comTrans women athletes may actually have disadvantages compared to cis womenApril 23, 2024 | msn.comTipperary’s CIS roads allocation is ‘a drop in the ocean’ of what is neededApril 23, 2024 | msn.comEven immigration restrictionists stay away from GOP’s ‘invasion’ rhetoricApril 22, 2024 | msn.com'It's acting, afterall': Internet agrees as Hilary Swank wants cis actors in trans roles and vice versaApril 20, 2024 | msn.comFamily rejection, social criticism, poverty- this lesbian couple has survived them allApril 20, 2024 | yahoo.comTrans Wrestler Nyla Rose Competed Against a Cis Wrestler. The State of Oklahoma Lost ItApril 19, 2024 | msn.comI Tried Biohacking My Way Out of a Health Rut — and the Results Were MixedApril 18, 2024 | bizjournals.comMaking Waves: Corporate Interior Systems Celebrating 40 Years in the ValleyApril 18, 2024 | msn.comIs ‘cis’ a slur? Understanding cisgender and its usageApril 16, 2024 | msn.comWhat Does “Cis” Mean, And Is It Bad?April 16, 2024 | msn.comThe Vast Majority of Mass Shooters Are Cis Men. Why Does the Right Keep Saying They're Trans?April 14, 2024 | msn.comTajik foreign minister hits out at Russia’s apparent torturing of terrorism accusedApril 14, 2024 | msn.com‘PWDs, single parents should get birth certificates for free’April 14, 2024 | msn.comParty-list wants free clearances for PWDs, solo parents applying for jobsApril 13, 2024 | msn.comJ.K. Rowling posts 700-word diatribe trying to justify her transphobiaApril 12, 2024 | msn.comStudy of trans athletes concludes blanket sports bans are a mistakeApril 12, 2024 | msn.comPANNIER: Caspian military drills that exclude Russia and Iran have some people in Moscow asking questionsSee More Headlines Receive CIS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (CIS) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:CIS CUSIPN/A CIK1487295 Webwww.camelotchina.com Phone+86-10-82019000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (NYSE:CIS) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (CIS) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
